Clinical Trial Update: Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating cordycepin plus pentostatin in patients with refractory acute lymphoblastic leukemia or chronic myeloid leukemia. The study cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• Cordycepin (cordycepin)
• Pentostatin (pentostatin)

Snippet

Sponsor: Boston Medical Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED